These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 195074

  • 21. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A.
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [Abstract] [Full Text] [Related]

  • 22. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan.
    Chen JY, Chen CJ, Liu MY, Cho SM, Hsu MM, Lynn TC, Shieh T, Tu SM, Beasley RP, Hwang LY.
    J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr Virus antibodies in patients with carcinoma of the nasopharynx and carcinoma of other sites in the head and neck.
    Sako K, Minowada J, Marchetta FC.
    Am J Surg; 1975 Oct; 130(4):437-9. PubMed ID: 170838
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC, Chen JY, Glaser R, Henle W.
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
    [Abstract] [Full Text] [Related]

  • 31. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE, Ruíz García R, Cuevas J, Le Riverand Morales E, Ascue M.
    Vopr Virusol; 1979 Mar 15; (4):392-9. PubMed ID: 225887
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
    Lynn TC, Hsieh RP, Chuang CY, Huang SC, Hsieh T, Tu SM.
    Laryngoscope; 1984 Nov 15; 94(11 Pt 1):1485-8. PubMed ID: 6092804
    [Abstract] [Full Text] [Related]

  • 37. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M.
    Int J Cancer; 2012 Jul 15; 131(2):406-16. PubMed ID: 21866545
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus serology in the control of nasopharyngeal carcinoma.
    Levine PH, Connelly RR, Milman G, Easton J.
    Cancer Detect Prev; 1988 Jul 15; 12(1-6):357-62. PubMed ID: 2846170
    [Abstract] [Full Text] [Related]

  • 39. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 15; 30(3):509-11. PubMed ID: 20335122
    [Abstract] [Full Text] [Related]

  • 40. Antibody to Epstein-Barr virus specific DNase in sera of nasopharyngeal carcinoma and other nine most common cancer patients in Taiwan.
    Hsu MM, Chen JY, Liu MY, Lynn TC, Tu SM, Yang CS.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug 15; 17(3):131-7. PubMed ID: 6096088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.